07 Sep Bio-Me selected as a partner in the PREVALUNG EU program developing predictive biomarkers associated with lung cancer risk
Posted at 08:52h
in Uncategorized
The PREVALUNG EU program aims to implement cancer risk stratification tools and personalized interventions to intercept lung cancer in cardiovascular patients. Bio-Me’s Precision Microbiome Profiling (PMP™) was chosen for high-throughput gut microbiome profiling....